Multifunctional opioid receptor ligands and methods of treating pain
AssigneeArizona Board of Regents on Behalf of the University of Arizona
InventorsYeon Sun Lee, Victor J. Hruby, Frank Porreca
Life of this patent
Estimating the term…
Abstract
Opioid receptor ligands (ORLs) that are multifunctional having agonist activity at mu opioid receptor (MOR), agonist activity at delta opioid receptor (DOR), and antagonist (or partial agonist) activity at kappa opioid receptor (KOR) are for the treatment of pain. The ORLs comprise peptide portions that are analogs derived from enkephalins, endomorphins, or [DArg2, Lys4]-dermorphine (DALDA), as well as tail portions that comprise a lipophilic molecule such as a 4-anilidopiperidine moiety.
Claims13
A method reducing pain without causing an opioid addiction in a subject in need thereof, the method comprising:
- administering a multifunctional compound, wherein said multifunctional compound is a mu opioid receptor (MOR) agonist, a delta opioid receptor (DOR) agonist, and a kappa opioid receptor (KOR) antagonist or partial agonist.
A method of modulating different opioid receptors, the method comprising blocking or limiting kappa opioid receptors (KOR) and activating mu opioid receptors (MOR) and delta opioid receptors (DOR) by using a multifunctional compound on said receptors, wherein said multifunctional compound is a MOR agonist, a DOR agonist, and KOR antagonist or partial agonist;
- wherein the multifunctional compound reduces opioid side effects.
A method of blocking kappa opioid receptors (KOR) and activating mu opioid receptors (MOR) and delta opioid receptors (DOR) in a subject in need thereof, the method comprising:
- administering a multifunctional compound to the subject, wherein said multifunctional compound is a MOR agonist, a DOR agonist, and KOR antagonist or partial agonist;
- wherein the multifunctional compound reduces opioid side effects in the subject.
Dependencies are inferred from the claim text.